We updated the design of this site on December 18, 2017. Learn more.
ClinicalTrials.gov
ClinicalTrials.gov Menu

AMP as a Better Delivery System of Adenosine

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00179010
Recruitment Status : Suspended (In process of renewing IND for AMP)
First Posted : September 15, 2005
Last Update Posted : February 4, 2015
Sponsor:
Information provided by (Responsible Party):
Italo Biaggioni, Vanderbilt University

Results Submitted - Not Posted on ClinicalTrials.gov
Results information has been submitted to ClinicalTrials.gov by the sponsor or investigator, but is not yet publicly available (or "posted") on ClinicalTrials.gov. The submitted information may not be available if it is pending Quality Control (QC) Review by the National Library of Medicine (NLM) or if issues identified during QC review are being addressed or corrected by the sponsor or investigator. NLM's limited QC review assesses for apparent errors, deficiencies, or inconsistencies. NLM staff do not verify the scientific validity or relevance of the submitted information.
  Recruitment Status : Suspended
  Estimated Primary Completion Date : January 2017
  Estimated Study Completion Date : January 2017

Submission Cycle Results Submitted to ClinicalTrials.gov Results Returned after Quality Control Review
1 July 13, 2015 August 6, 2015
2 July 6, 2016 August 15, 2016
3 November 17, 2016 January 12, 2017
4 January 16, 2017 March 3, 2017
5 June 1, 2017 January 10, 2018